News | RIVM

Can you solve a medical mystery?

During World Antibiotic Awareness Week 2019, RIVM has set up an escape room in one of busiest shopping malls in the Netherlands.

Discussion regarding health-based guidance value of PFOA

The European Food Safety Authority (EFSA) has published a provisional health-based guidance value for perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA).

Teen vaccination against meningococcal disease starts

From mid-September, young people born between 1 May and 31 December 2004 will receive an invitation for a vaccination against meningococcal disease.

Meningococcal type W most notable infectious disease in 2017

The report ‘State of Infectious Diseases in the Netherlands in 2017’ published by RIVM today, provides an overview of the most important developments in infectious diseases in the Netherlands and a

Meningococcal disease serious, but still rare

Meningococcal disease is a disease caused by a bacterium, the meningococcus. There are several types of this bacterium. In most cases, it does not make you ill.

Bacteria slightly more often resistant to last resort antibiotics

Antimicrobial resistance is a global problem. In the Netherlands, some bacteria that can cause infections in people are more frequently resistant to antibiotics used as a last resort.

European Antibiotic Awareness Day: the fight against antibiotics resistance

Wednesday, 18 November is European Antibiotic Awareness Day. On this day, attention throughout Europe is requested for the responsible use of antibiotics in people and animals.

CAESAR annual report 2014

The World Health Organization (WHO) published its first CAESAR annual report 2014.

Antibiotic resistance is stable, however, more resistant bacteria are expected

Over recent years, antibiotic resistance to most agents has remained stable in the Netherlands, and the use of antibiotics has slightly decreased.

RIVM designated as WHO Collaborating Centre Antimicrobial Resistance Epidemiology and Surveillance

AMR is one of the major global challenges in infectious disease control.